,Set,NGenes,Direction,PValue,FDR
1,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,15,Down,0.000102746177984715,0.0844573583034361
2,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,35,Down,0.0002985751306793,0.122714378709192
3,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,5,Up,0.00139664361552233,0.358909459984014
4,WP_IRON_METABOLISM_IN_PLACENTA,9,Down,0.0018297168873719,0.358909459984014
5,WP_VITAMIN_B12_METABOLISM,23,Down,0.00218314756681274,0.358909459984014
6,WP_IRON_METABOLISM_DISORDERS,12,Down,0.00285393900194954,0.390989643267087
7,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,24,Down,0.00346308870488332,0.40666555934487
8,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,9,Down,0.00446390883978389,0.458666633287795
9,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.00603946000315008,0.55160401362104
10,WP_ASPIRIN_AND_MIRNAS,8,Down,0.00675741651461212,0.555459637501116
11,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.00851908342144555,0.583151598027935
12,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.00960368557142664,0.583151598027935
13,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.00960744254932174,0.583151598027935
14,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.0109413379098889,0.583151598027935
15,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.011100272636005,0.583151598027935
16,WP_SPINAL_CORD_INJURY,65,Down,0.0113508826866751,0.583151598027935
17,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.013098185969385,0.609960559451078
18,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,14,Down,0.0140213312666299,0.609960559451078
19,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.0142661099293687,0.609960559451078
20,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.014925037127531,0.609960559451078
21,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Up,0.0162892899508266,0.609960559451078
22,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.0163249784767928,0.609960559451078
23,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.0181710157498597,0.640627791853525
24,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.0195659533083332,0.640627791853525
25,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.019991900495183,0.640627791853525
26,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Down,0.0207780749250522,0.640627791853525
27,WP_ARYLAMINE_METABOLISM,1,Up,0.0225065267162949,0.640627791853525
28,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.0225972273885192,0.640627791853525
29,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.0226012238001852,0.640627791853525
30,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.0253302305591643,0.657585582538851
31,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Down,0.0254522800068108,0.657585582538851
32,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Down,0.0256165553409197,0.657585582538851
33,WP_FOLATE_METABOLISM,36,Down,0.0268160224044458,0.657585582538851
34,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.0271994036573248,0.657585582538851
35,WP_IL26_SIGNALING,31,Down,0.0283579886373137,0.666007618853481
36,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.0307900034518733,0.685137883748554
37,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Down,0.0313891104065258,0.685137883748554
38,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,76,Down,0.0324856640462483,0.685137883748554
39,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.0325065419296759,0.685137883748554
40,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Down,0.0348108767978187,0.715363518195174
41,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.0373693040904706,0.721587650587466
42,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Down,0.0380385353081306,0.721587650587466
43,WP_LIPID_PARTICLES_COMPOSITION,5,Down,0.0407477183452509,0.721587650587466
44,WP_METHYLATION_PATHWAYS,5,Up,0.0408974381739783,0.721587650587466
45,WP_NUCLEAR_RECEPTORS,20,Down,0.0416443627155178,0.721587650587466
46,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.0445206877633847,0.721587650587466
47,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.0450069586158892,0.721587650587466
48,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.0458846710630187,0.721587650587466
49,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Down,0.0465374410989358,0.721587650587466
50,WP_PROSTAGLANDIN_SIGNALING,21,Down,0.0470174475085446,0.721587650587466
51,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.0480204099857315,0.721587650587466
52,WP_RANKLRANK_SIGNALING,48,Down,0.0481889890222867,0.721587650587466
53,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,17,Down,0.0494109132853967,0.721587650587466
54,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,63,Down,0.0494755910245329,0.721587650587466
55,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,12,Up,0.0500436578536363,0.721587650587466
56,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Up,0.0524983816122127,0.721587650587466
57,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.0541778102833665,0.721587650587466
58,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,53,Down,0.0559059729642479,0.721587650587466
59,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,20,Down,0.059335027689791,0.721587650587466
60,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,24,Up,0.0601650258590746,0.721587650587466
61,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.0604645956815569,0.721587650587466
62,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.0621816543229102,0.721587650587466
63,WP_GASTRIC_CANCER_NETWORK_2,27,Down,0.0626896359168174,0.721587650587466
64,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.0633834535340554,0.721587650587466
65,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.0634058125381982,0.721587650587466
66,WP_GPCRS_OTHER,11,Down,0.0641968147034791,0.721587650587466
67,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.0655249665618713,0.721587650587466
68,WP_HEME_BIOSYNTHESIS,8,Down,0.0655249665618713,0.721587650587466
69,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,61,Down,0.0661419480533401,0.721587650587466
70,WP_DOPAMINE_METABOLISM,7,Up,0.0668572662897082,0.721587650587466
71,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.0672137211118553,0.721587650587466
72,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.0678306175258765,0.721587650587466
73,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,12,Up,0.0692400982450868,0.721587650587466
74,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Down,0.0694360366205484,0.721587650587466
75,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.0717670747345538,0.721587650587466
76,WP_MEVALONATE_PATHWAY,7,Up,0.072254638049391,0.721587650587466
77,WP_WNT_SIGNALING_WP363,37,Down,0.072278601328178,0.721587650587466
78,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.0733610355994925,0.721587650587466
79,WP_BURN_WOUND_HEALING,60,Down,0.0740978065814029,0.721587650587466
80,WP_SPINA_BIFIDA,10,Down,0.0746232052891779,0.721587650587466
81,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,5,Down,0.0751299764835304,0.721587650587466
82,WP_HYPERTROPHY_MODEL,13,Down,0.075374650212457,0.721587650587466
83,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.0755350166509675,0.721587650587466
84,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.076029413360569,0.721587650587466
85,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,88,Down,0.0765079594129946,0.721587650587466
86,WP_INTEGRINMEDIATED_CELL_ADHESION,71,Down,0.0782130953255838,0.721587650587466
87,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Down,0.0786426254780893,0.721587650587466
88,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Up,0.0789463325315589,0.721587650587466
89,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.0791894891335398,0.721587650587466
90,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.0796439880398876,0.721587650587466
91,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.0808033584619283,0.721587650587466
92,WP_RETT_SYNDROME,31,Down,0.0824343823131907,0.721587650587466
93,WP_ENDODERM_DIFFERENTIATION,80,Down,0.0829819201248368,0.721587650587466
94,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.0837142851246179,0.721587650587466
95,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.0840098105664345,0.721587650587466
96,WP_KALLMANN_SYNDROME,11,Up,0.0850472185768858,0.721587650587466
97,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,15,Down,0.0859186655269012,0.721587650587466
98,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.086028698001912,0.721587650587466
99,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.087757736848505,0.728655148378496
100,WP_SYNAPTIC_VESICLE_PATHWAY,20,Down,0.089907867242438,0.731739557608239
101,WP_SERINE_METABOLISM,8,Up,0.0903375183237012,0.731739557608239
102,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,0.0921589437049496,0.731739557608239
103,WP_BENZENE_METABOLISM,3,Up,0.0923246775035343,0.731739557608239
104,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.0937946926516935,0.731739557608239
105,WP_PLEURAL_MESOTHELIOMA,251,Down,0.0961629016427599,0.731739557608239
106,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,25,Down,0.096179493876528,0.731739557608239
107,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.0969204820097358,0.731739557608239
108,WP_AMINO_ACID_METABOLISM,57,Up,0.0969693976996724,0.731739557608239
109,WP_PEPTIDE_GPCRS,11,Up,0.0976395640637704,0.731739557608239
110,WP_10Q22Q23_COPY_NUMBER_VARIATION,28,Up,0.0979213519913701,0.731739557608239
111,WP_LUNG_PATHOLOGY_OF_COVID19,13,Down,0.103789186378486,0.737937679460085
112,WP_COMPLEMENT_AND_COAGULATION_CASCADES,24,Up,0.104625321442514,0.737937679460085
113,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,24,Up,0.104625321442514,0.737937679460085
114,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.104683864997284,0.737937679460085
115,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Down,0.104741044140006,0.737937679460085
116,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Down,0.105183823598398,0.737937679460085
117,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.106005749135436,0.737937679460085
118,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,20,Down,0.106094564922992,0.737937679460085
119,WP_CILIOPATHIES,126,Up,0.107423135498817,0.737937679460085
120,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.107728128388334,0.737937679460085
121,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,47,Down,0.111646253530369,0.758456366958376
122,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.114642730572478,0.768265838243043
123,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.115674422975584,0.768265838243043
124,WP_TAMOXIFEN_METABOLISM,2,Up,0.11709366052799,0.768265838243043
125,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,0.117331759907239,0.768265838243043
126,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,39,Up,0.118376743140462,0.768265838243043
127,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,8,Down,0.118698006638524,0.768265838243043
128,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.120958601386228,0.773084515506604
129,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,88,Up,0.122751653447736,0.773084515506604
130,WP_JOUBERT_SYNDROME,70,Up,0.123172684150065,0.773084515506604
131,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.123204466583169,0.773084515506604
132,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.127435410076465,0.781926659240211
133,WP_OREXIN_RECEPTOR_PATHWAY,116,Down,0.128906385640299,0.781926659240211
134,WP_MEASLES_VIRUS_INFECTION,101,Up,0.131665473613509,0.781926659240211
135,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.132274875047709,0.781926659240211
136,WP_SILDENAFIL_TREATMENT,11,Down,0.133996447436738,0.781926659240211
137,WP_DNA_MISMATCH_REPAIR,23,Down,0.134610665915418,0.781926659240211
138,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Down,0.134708951283357,0.781926659240211
139,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.134924573849695,0.781926659240211
140,WP_NEPHROGENESIS,4,Down,0.135118626036051,0.781926659240211
141,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.135515523040984,0.781926659240211
142,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Down,0.138215621829341,0.781926659240211
143,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.138354494777581,0.781926659240211
144,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,8,Up,0.138887510341008,0.781926659240211
145,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.139009966985451,0.781926659240211
146,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.139045075173067,0.781926659240211
147,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,24,Down,0.140786513461798,0.781926659240211
148,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.140864685690494,0.781926659240211
149,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.141736097599503,0.781926659240211
150,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.143672867089195,0.783797193795859
151,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.145386838162782,0.783797193795859
152,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.146835408741123,0.783797193795859
153,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,14,Down,0.147359750964062,0.783797193795859
154,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,16,Down,0.147510105745558,0.783797193795859
155,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.147834947023544,0.783797193795859
156,WP_IL18_SIGNALING,191,Down,0.148889276959812,0.783797193795859
157,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.151389586105495,0.783797193795859
158,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.151850006591289,0.783797193795859
159,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.153957222049584,0.783797193795859
160,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.155232180192093,0.783797193795859
161,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.155690697626714,0.783797193795859
162,WP_TYPE_II_INTERFERON_SIGNALING,29,Up,0.155782745120972,0.783797193795859
163,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.156243522732344,0.783797193795859
164,WP_DRAVET_SYNDROME,12,Down,0.156907442991539,0.783797193795859
165,WP_SEROTONIN_AND_ANXIETY,6,Down,0.160500755145509,0.783797193795859
166,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,40,Down,0.162334409278827,0.783797193795859
167,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.163822120346366,0.783797193795859
168,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Down,0.164185743395676,0.783797193795859
169,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.164663874469959,0.783797193795859
170,WP_OPIOID_RECEPTOR_PATHWAYS,25,Down,0.164686648760328,0.783797193795859
171,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.169020686494834,0.783797193795859
172,WP_BARDETBIEDL_SYNDROME,64,Up,0.170862653710198,0.783797193795859
173,WP_INSULIN_SIGNALING,130,Down,0.17309885064971,0.783797193795859
174,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.174057690408907,0.783797193795859
175,WP_EGFEGFR_SIGNALING,138,Down,0.176095287769306,0.783797193795859
176,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.17876523283191,0.783797193795859
177,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,44,Down,0.184731544522287,0.783797193795859
178,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.184829260528186,0.783797193795859
179,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Up,0.185532353930462,0.783797193795859
180,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Down,0.186179475691146,0.783797193795859
181,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.186318681333124,0.783797193795859
182,WP_PROLACTIN_SIGNALING,69,Down,0.186326609753944,0.783797193795859
183,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Down,0.186696265700561,0.783797193795859
184,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.187100086443337,0.783797193795859
185,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.189985769431545,0.783797193795859
186,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.190264640929558,0.783797193795859
187,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.191657692400778,0.783797193795859
188,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.192614566151403,0.783797193795859
189,WP_ALLOGRAFT_REJECTION,49,Down,0.193340594484768,0.783797193795859
190,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.194107715800954,0.783797193795859
191,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,45,Down,0.194361978161257,0.783797193795859
192,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.194720539597064,0.783797193795859
193,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Up,0.195006386102825,0.783797193795859
194,WP_GLUTATHIONE_METABOLISM,10,Up,0.19603993253456,0.783797193795859
195,WP_MAPK_SIGNALING,159,Down,0.196980405478994,0.783797193795859
196,WP_SMALL_CELL_LUNG_CANCER,68,Down,0.197050904818922,0.783797193795859
197,WP_ERBB_SIGNALING,68,Down,0.197087496572024,0.783797193795859
198,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,53,Down,0.198248665542917,0.783797193795859
199,WP_MRNA_PROCESSING,124,Down,0.199778770383066,0.783797193795859
200,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.200214535423823,0.783797193795859
201,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Down,0.201147458945551,0.783797193795859
202,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.201152110716405,0.783797193795859
203,WP_GLYOXYLATE_METABOLISM,5,Up,0.202176618850865,0.783797193795859
204,WP_PURINE_METABOLISM,10,Down,0.20260167380844,0.783797193795859
205,WP_IRINOTECAN_PATHWAY,5,Up,0.202759505390513,0.783797193795859
206,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,48,Down,0.203789410634942,0.783797193795859
207,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.204176691445907,0.783797193795859
208,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.205335528335284,0.783797193795859
209,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.206351402455885,0.783797193795859
210,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,86,Down,0.206999583506242,0.783797193795859
211,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.208052122505605,0.783797193795859
212,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,9,Down,0.208256753622586,0.783797193795859
213,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.209258055192698,0.783797193795859
214,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Up,0.210278437217655,0.783797193795859
215,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.21033001698525,0.783797193795859
216,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.210604259877805,0.783797193795859
217,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,63,Up,0.212400924261511,0.783797193795859
218,WP_NETRINUNC5B_SIGNALING,34,Down,0.21408145309937,0.783797193795859
219,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.21770381360574,0.783797193795859
220,WP_BENZOAPYRENE_METABOLISM,5,Up,0.217882033573636,0.783797193795859
221,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Up,0.218633516564184,0.783797193795859
222,WP_IL1_SIGNALING,53,Down,0.218997786717015,0.783797193795859
223,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Down,0.219011891999548,0.783797193795859
224,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.219639787732555,0.783797193795859
225,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.219903802059892,0.783797193795859
226,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,10,Up,0.220359090595135,0.783797193795859
227,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.221328748021361,0.783797193795859
228,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Down,0.22204877603292,0.783797193795859
229,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Down,0.222390512315077,0.783797193795859
230,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,25,Down,0.222447019895173,0.783797193795859
231,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.223557232981654,0.783797193795859
232,WP_FATTY_ACID_BETAOXIDATION,28,Up,0.224128167454476,0.783797193795859
233,WP_NAD_METABOLISM,11,Down,0.22551785965373,0.783797193795859
234,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.22740531459463,0.783797193795859
235,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Up,0.229944563286413,0.783797193795859
236,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,20,Down,0.230001629165571,0.783797193795859
237,WP_ACUTE_MYELOID_LEUKEMIA,56,Up,0.230524126399049,0.783797193795859
238,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,58,Down,0.230615933077011,0.783797193795859
239,WP_B_CELL_RECEPTOR_SIGNALING,86,Down,0.234573432443547,0.783797193795859
240,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,6,Down,0.236098062480255,0.783797193795859
241,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.236272406194394,0.783797193795859
242,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.236933760816513,0.783797193795859
243,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.238285983874407,0.783797193795859
244,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.238285983874407,0.783797193795859
245,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,30,Down,0.238359735338256,0.783797193795859
246,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,11,Up,0.239137261774349,0.783797193795859
247,WP_IDO_METABOLIC_PATHWAY,6,Down,0.240219029825009,0.783797193795859
248,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Up,0.242049751153882,0.783797193795859
249,WP_DNA_REPLICATION,41,Down,0.242778797365893,0.783797193795859
250,WP_PREIMPLANTATION_EMBRYO,21,Down,0.242790938055829,0.783797193795859
251,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.242857007353394,0.783797193795859
252,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.243143401129651,0.783797193795859
253,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.243357957277609,0.783797193795859
254,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.244226082100107,0.783797193795859
255,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,66,Down,0.24449797148585,0.783797193795859
256,WP_AGERAGE_PATHWAY,54,Down,0.244840460246137,0.783797193795859
257,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Down,0.245949014040645,0.783797193795859
258,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.2460093381987,0.783797193795859
259,WP_NEURAL_CREST_DIFFERENTIATION,38,Down,0.247097441181774,0.784224311395438
260,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.249529766778258,0.786290812148973
261,WP_ALSTROM_SYNDROME,26,Up,0.249661681229783,0.786290812148973
262,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.253314756329725,0.786923601053488
263,WP_CORI_CYCLE,11,Down,0.253568012976428,0.786923601053488
264,WP_CAMKK2_PATHWAY,29,Down,0.253572945921652,0.786923601053488
265,WP_RETINOBLASTOMA_GENE_IN_CANCER,85,Down,0.253844137403765,0.786923601053488
266,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.255484079097412,0.786923601053488
267,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.256231719951452,0.786923601053488
268,WP_CHEMOKINE_SIGNALING,105,Down,0.256563899126928,0.786923601053488
269,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.259104296023657,0.789251301815045
270,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,20,Down,0.259243128333409,0.789251301815045
271,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,35,Down,0.260409217289035,0.789437670795251
272,WP_KLEEFSTRA_SYNDROME,24,Down,0.262196707755851,0.789437670795251
273,WP_16P112_DISTAL_DELETION_SYNDROME,21,Down,0.262332450550102,0.789437670795251
274,WP_KREBS_CYCLE_DISORDERS,11,Up,0.263251272107239,0.789437670795251
275,WP_NEOVASCULARIZATION_PROCESSES,22,Down,0.264106276725905,0.789437670795251
276,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.2666554510413,0.794169495492567
277,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Up,0.275790437536942,0.815654319591444
278,WP_ETHER_LIPID_BIOSYNTHESIS,15,Up,0.275999738840003,0.815654319591444
279,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,27,Up,0.277853006539938,0.815654319591444
280,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,10,Up,0.278162432157034,0.815654319591444
281,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,89,Down,0.2800856882622,0.815654319591444
282,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Down,0.281392125361013,0.815654319591444
283,WP_FOXA2_PATHWAY,9,Down,0.282485037119117,0.815654319591444
284,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.282699605425122,0.815654319591444
285,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,79,Down,0.284198941651504,0.815654319591444
286,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,8,Down,0.286317661008349,0.815654319591444
287,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,8,Down,0.286317661008349,0.815654319591444
288,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.287418185063998,0.815654319591444
289,WP_MACROPHAGE_MARKERS,8,Down,0.289148839630067,0.815654319591444
290,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.290673844418386,0.815654319591444
291,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.291385092059047,0.815654319591444
292,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.29154571372303,0.815654319591444
293,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.292894923378479,0.815654319591444
294,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Down,0.293439139783749,0.815654319591444
295,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.294945898658136,0.815654319591444
296,WP_SMALL_LIGAND_GPCRS,7,Up,0.295225814104759,0.815654319591444
297,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.29560888850864,0.815654319591444
298,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.295699497856752,0.815654319591444
299,WP_UROTENSINIIMEDIATED_SIGNALING,50,Down,0.297198251861565,0.817046699097679
300,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Down,0.301792381271509,0.817146866155476
301,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,77,Down,0.301805592159459,0.817146866155476
302,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.302173952410224,0.817146866155476
303,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Down,0.303266607661339,0.817146866155476
304,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.303551052785696,0.817146866155476
305,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.305440820547762,0.817146866155476
306,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.30548287336525,0.817146866155476
307,WP_FOXP3_IN_COVID19,9,Down,0.305493980708662,0.817146866155476
308,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,34,Down,0.306181550822246,0.817146866155476
309,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Down,0.308174498955351,0.817447625252037
310,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Down,0.308369286913339,0.817447625252037
311,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.309277629505333,0.817447625252037
312,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,47,Down,0.311209794041701,0.819918111225251
313,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.313676527340537,0.821591096927188
314,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.313843801015982,0.821591096927188
315,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,14,Down,0.31489573829767,0.821727926605349
316,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,81,Down,0.317475825086123,0.825839013356941
317,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,16,Down,0.322204867432243,0.827645869989579
318,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,38,Down,0.323702135669569,0.827645869989579
319,WP_TGFB_SMAD_SIGNALING,7,Down,0.325466535749473,0.827645869989579
320,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Down,0.326883826007571,0.827645869989579
321,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,12,Down,0.32710786574381,0.827645869989579
322,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.328687000632057,0.827645869989579
323,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.329350020520441,0.827645869989579
324,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,62,Down,0.330909836864166,0.827645869989579
325,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.331120437316534,0.827645869989579
326,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.33112372179845,0.827645869989579
327,WP_GALANIN_RECEPTOR_PATHWAY,10,Down,0.33221202174279,0.827645869989579
328,WP_NUCLEOTIDE_EXCISION_REPAIR,44,Down,0.332414825667919,0.827645869989579
329,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.333073766959933,0.827645869989579
330,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Up,0.333100629167354,0.827645869989579
331,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,15,Down,0.333475242841331,0.827645869989579
332,WP_OSTEOCLAST_SIGNALING,8,Up,0.334280327051752,0.827645869989579
333,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Down,0.338023460686347,0.829200562206197
334,WP_CHOLESTASIS,9,Up,0.338061169123344,0.829200562206197
335,WP_NANOMATERIAL_INDUCED_APOPTOSIS,17,Up,0.33972291583554,0.829200562206197
336,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,171,Down,0.341571220574209,0.829200562206197
337,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,29,Down,0.34160120995284,0.829200562206197
338,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.3416962721873,0.829200562206197
339,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,67,Down,0.343394720251127,0.829200562206197
340,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.345359024525248,0.829200562206197
341,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.345692458937858,0.829200562206197
342,WP_ONECARBON_METABOLISM,23,Down,0.346642314150607,0.829200562206197
343,WP_REGULATION_OF_ACTIN_CYTOSKELETON,91,Down,0.347105418386984,0.829200562206197
344,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.348261698944317,0.829200562206197
345,WP_VITAMIN_D_RECEPTOR_PATHWAY,82,Down,0.349045793776569,0.829200562206197
346,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.351481044728737,0.829200562206197
347,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,50,Up,0.351649721081333,0.829200562206197
348,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.351811826700312,0.829200562206197
349,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,9,Down,0.352057173004821,0.829200562206197
350,WP_HEART_DEVELOPMENT,16,Up,0.353978511066736,0.831343817419592
351,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.35874710359092,0.839974230394783
352,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.359696994037669,0.839974230394783
353,WP_CIRCADIAN_RHYTHM_GENES,118,Down,0.361655162175403,0.84215451362091
354,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Up,0.363829674076551,0.844824836415043
355,WP_MICROTUBULE_CYTOSKELETON_REGULATION,36,Down,0.365636443340273,0.845815415872303
356,WP_ENDOTHELIN_PATHWAYS,12,Up,0.366314219039586,0.845815415872303
357,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,10,Down,0.367466937018696,0.846100342379183
358,WP_AFLATOXIN_B1_METABOLISM,2,Down,0.372135600221143,0.854161681660516
359,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Down,0.373589762399941,0.854161681660516
360,WP_GASTRIN_SIGNALING,92,Down,0.374679484807695,0.854161681660516
361,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.376710122497612,0.854161681660516
362,WP_HIPPO_SIGNALING_REGULATION,44,Down,0.376737935906645,0.854161681660516
363,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.377202786426724,0.854161681660516
364,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.379344981338738,0.856652677638578
365,WP_NUCLEAR_RECEPTORS_METAPATHWAY,171,Down,0.381854238209212,0.857258118433711
366,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.382693852429755,0.857258118433711
367,WP_PRION_DISEASE_PATHWAY,28,Up,0.382741763339625,0.857258118433711
368,WP_ENERGY_METABOLISM,40,Down,0.390151839344592,0.867804424085909
369,WP_TGFBETA_RECEPTOR_SIGNALING,35,Down,0.390584531838109,0.867804424085909
370,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,24,Down,0.391320338554799,0.867804424085909
371,WP_PPAR_SIGNALING,38,Up,0.391673286296682,0.867804424085909
372,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,40,Down,0.392759574658026,0.86787196335725
373,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,49,Down,0.400103604026776,0.878267591732854
374,WP_FOCAL_ADHESION,114,Down,0.40106182558471,0.878267591732854
375,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.402864945433256,0.878267591732854
376,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Down,0.403889936315506,0.878267591732854
377,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.40401358140375,0.878267591732854
378,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.406343329136478,0.878267591732854
379,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.406967450871727,0.878267591732854
380,WP_BASE_EXCISION_REPAIR,31,Down,0.409438626048338,0.878267591732854
381,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.410788648696147,0.878267591732854
382,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Down,0.411461669459421,0.878267591732854
383,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.412570979336418,0.878267591732854
384,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Down,0.41368089517913,0.878267591732854
385,WP_PYRIMIDINE_METABOLISM,74,Down,0.414001782620342,0.878267591732854
386,WP_MAPK_CASCADE,30,Down,0.414316462686994,0.878267591732854
387,WP_CELL_DIFFERENTIATION_INDEX,6,Up,0.414322991308387,0.878267591732854
388,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.415126129307398,0.878267591732854
389,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.416447931697536,0.878267591732854
390,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.418286200848642,0.878267591732854
391,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.420903521702963,0.878267591732854
392,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,135,Down,0.422362220798407,0.878267591732854
393,WP_ATR_SIGNALING,10,Down,0.423254447201073,0.878267591732854
394,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,40,Down,0.423509555216807,0.878267591732854
395,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.424323907363852,0.878267591732854
396,WP_FERROPTOSIS,50,Up,0.424421727444084,0.878267591732854
397,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.425041646465446,0.878267591732854
398,WP_TNFALPHA_SIGNALING,83,Down,0.426106491682624,0.878267591732854
399,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.427070407661158,0.878267591732854
400,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.427951776502086,0.878267591732854
401,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Up,0.428449275285735,0.878267591732854
402,WP_GENES_CONTROLLING_NEPHROGENESIS,12,Down,0.430358013298123,0.879985788385714
403,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.431596172867014,0.880327677659269
404,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.437991113251304,0.889085539339933
405,WP_EBOLA_VIRUS_INFECTION_IN_HOST,108,Down,0.439204463409801,0.889085539339933
406,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.439255130433674,0.889085539339933
407,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Down,0.440358341944504,0.889085539339933
408,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,28,Down,0.441297931935149,0.889085539339933
409,WP_GLYCOLYSIS_IN_SENESCENCE,10,Down,0.443230763466766,0.889247600829484
410,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.443541990681373,0.889247600829484
411,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.446481103419095,0.891376898261993
412,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,26,Down,0.44741131377101,0.891376898261993
413,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Down,0.447857249370077,0.891376898261993
414,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.449216338929273,0.891922296134933
415,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.452916707091255,0.894945993338971
416,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.452916707091255,0.894945993338971
417,WP_IL7_SIGNALING,22,Up,0.45795754207692,0.899810283188122
418,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.458375056439152,0.899810283188122
419,WP_IL2_SIGNALING,36,Up,0.458662419289323,0.899810283188122
420,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Down,0.460663016026314,0.901583331365787
421,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,57,Up,0.463094674690409,0.902795049906446
422,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,21,Down,0.46448773024931,0.902795049906446
423,WP_IL9_SIGNALING,14,Up,0.464577014732879,0.902795049906446
424,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.466598400708604,0.90458463533602
425,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,24,Down,0.468730083608283,0.906579126414139
426,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Down,0.472451069047235,0.911207277876949
427,WP_ACUTE_VIRAL_MYOCARDITIS,63,Up,0.474387861471564,0.911207277876949
428,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.474448558310625,0.911207277876949
429,WP_ID_SIGNALING,12,Down,0.47900297130425,0.914350388973145
430,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Down,0.479278426035763,0.914350388973145
431,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Down,0.480831872833999,0.914350388973145
432,WP_CILIARY_LANDSCAPE,185,Up,0.480893995847056,0.914350388973145
433,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.481646859398262,0.914350388973145
434,WP_ONCOSTATIN_M_SIGNALING,54,Down,0.484710430511488,0.916506252247522
435,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Down,0.485012432758725,0.916506252247522
436,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,22,Down,0.488186169082131,0.920387685746586
437,WP_AXON_GUIDANCE,35,Down,0.49179925052221,0.921293261713445
438,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.492774408513603,0.921293261713445
439,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.49280277070015,0.921293261713445
440,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.494724344546694,0.921293261713445
441,WP_G1_TO_S_CELL_CYCLE_CONTROL,57,Down,0.494914679328823,0.921293261713445
442,WP_LEPTIN_SIGNALING,70,Down,0.495391267247375,0.921293261713445
443,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.500977550209224,0.929262834023652
444,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,72,Down,0.502181125707037,0.929262834023652
445,WP_DOPAMINERGIC_NEUROGENESIS,4,Down,0.504142399136611,0.929262834023652
446,WP_ACE_INHIBITOR_PATHWAY,4,Down,0.505485766518214,0.929262834023652
447,WP_4P163_COPY_NUMBER_VARIATION,22,Up,0.507285341458889,0.929262834023652
448,WP_OSTEOBLAST_SIGNALING,2,Up,0.507592168036878,0.929262834023652
449,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,75,Down,0.507952745785862,0.929262834023652
450,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.508745612528315,0.929262834023652
451,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.511002317335293,0.929262834023652
452,WP_MESODERMAL_COMMITMENT_PATHWAY,75,Down,0.513077934313204,0.929262834023652
453,WP_KETOGENESIS_AND_KETOLYSIS,7,Up,0.51490642274162,0.929262834023652
454,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,62,Down,0.516085077553447,0.929262834023652
455,WP_PRIMARY_OVARIAN_INSUFFICIENCY,96,Down,0.517648028258302,0.929262834023652
456,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,12,Up,0.518025941318419,0.929262834023652
457,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.518244799988465,0.929262834023652
458,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Up,0.519013869839918,0.929262834023652
459,WP_OSTEOPONTIN_SIGNALING,11,Down,0.520838275797074,0.929262834023652
460,WP_INFLAMMATORY_RESPONSE_PATHWAY,13,Down,0.521100305572203,0.929262834023652
461,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Down,0.522300819992957,0.929262834023652
462,WP_IL11_SIGNALING,41,Up,0.524360808717242,0.929262834023652
463,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Down,0.524555361149285,0.929262834023652
464,WP_PDGF_PATHWAY,36,Down,0.527888394185511,0.929262834023652
465,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,0.528905320382622,0.929262834023652
466,WP_MATRIX_METALLOPROTEINASES,8,Up,0.531881268622922,0.929262834023652
467,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.533253458231709,0.929262834023652
468,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,49,Down,0.534949521275655,0.929262834023652
469,WP_ULCERATIVE_COLITIS_SIGNALING,12,Down,0.537085707022165,0.929262834023652
470,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.53799448577454,0.929262834023652
471,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Up,0.538792304438216,0.929262834023652
472,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.539148889018215,0.929262834023652
473,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,48,Down,0.539291625103411,0.929262834023652
474,WP_MELANOMA,56,Down,0.540212163910035,0.929262834023652
475,WP_ADIPOGENESIS,83,Down,0.540780572108388,0.929262834023652
476,WP_HIPPOYAP_SIGNALING,16,Down,0.541167554054961,0.929262834023652
477,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.54343934877628,0.929262834023652
478,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.544158595715541,0.929262834023652
479,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.54441773882581,0.929262834023652
480,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Up,0.546134104105784,0.929262834023652
481,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.546300959184993,0.929262834023652
482,WP_KININKALLIKREIN_PATHWAY,2,Up,0.546980271184234,0.929262834023652
483,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.548941292716011,0.929262834023652
484,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.550162576735899,0.929262834023652
485,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.551115120315929,0.929262834023652
486,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.551178785795953,0.929262834023652
487,WP_ALPHA_6_BETA_4_SIGNALING,24,Down,0.551563779224393,0.929262834023652
488,WP_15Q11Q13_COPY_NUMBER_VARIATION,30,Down,0.551679152072436,0.929262834023652
489,WP_NUCLEOTIDE_GPCRS,5,Up,0.554439689614491,0.930101546003508
490,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.554440094332992,0.930101546003508
491,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.556560085574001,0.930237533762996
492,WP_TOLLLIKE_RECEPTOR_SIGNALING,78,Down,0.558523137376877,0.930237533762996
493,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Up,0.558838062591332,0.930237533762996
494,WP_HOMOLOGOUS_RECOMBINATION,13,Up,0.559375837050286,0.930237533762996
495,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Up,0.560179536755089,0.930237533762996
496,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.561535163609746,0.930608678401635
497,WP_TCELL_RECEPTOR_SIGNALING,72,Down,0.56303019282422,0.931208890345089
498,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.56511162331457,0.931827545052914
499,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.565671465914117,0.931827545052914
500,WP_PI3KAKT_SIGNALING,175,Up,0.567561420318541,0.93234732781349
501,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Up,0.568255488119901,0.93234732781349
502,WP_BLOOD_CLOTTING_CASCADE,6,Up,0.572038995349847,0.936685366887598
503,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Up,0.575271459564129,0.937525709886996
504,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,84,Down,0.57605794716385,0.937525709886996
505,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.577020415574135,0.937525709886996
506,WP_MONOAMINE_GPCRS,3,Down,0.578226901911623,0.937525709886996
507,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,75,Down,0.578254908652928,0.937525709886996
508,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.581970293167213,0.938964364373595
509,WP_ESTROGEN_SIGNALING,21,Down,0.582264109525346,0.938964364373595
510,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.582569131180697,0.938964364373595
511,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.585811571998552,0.941225205294422
512,WP_16P112_PROXIMAL_DELETION_SYNDROME,60,Down,0.586261928358569,0.941225205294422
513,WP_MTHFR_DEFICIENCY,18,Down,0.589227201000029,0.944141830842151
514,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.59063535874565,0.944556935581565
515,WP_TP53_NETWORK,16,Down,0.595233597492861,0.946452158035139
516,WP_13Q1212_COPY_NUMBER_VARIATION,19,Down,0.595803480487298,0.946452158035139
517,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,43,Down,0.59719494200329,0.946452158035139
518,WP_VEGFAVEGFR2_SIGNALING,342,Down,0.598245268713581,0.946452158035139
519,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.603649147675148,0.946452158035139
520,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.604232848880759,0.946452158035139
521,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.605369634641888,0.946452158035139
522,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Up,0.606628836626693,0.946452158035139
523,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Down,0.609010426434445,0.946452158035139
524,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,34,Up,0.610496541528529,0.946452158035139
525,WP_INTEGRATED_CANCER_PATHWAY,41,Down,0.612595580398764,0.946452158035139
526,WP_ECTODERM_DIFFERENTIATION,75,Down,0.613064287006431,0.946452158035139
527,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.614645623757661,0.946452158035139
528,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.614942247857637,0.946452158035139
529,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.615122004871968,0.946452158035139
530,WP_TAR_SYNDROME,44,Down,0.616154402200378,0.946452158035139
531,WP_MONOAMINE_TRANSPORT,12,Up,0.616223912024076,0.946452158035139
532,WP_NOTCH_SIGNALING_WP268,35,Down,0.620511499403575,0.946452158035139
533,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.622643228801231,0.946452158035139
534,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.622868323539309,0.946452158035139
535,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Down,0.625227671567778,0.946452158035139
536,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.625373510382962,0.946452158035139
537,WP_GLUCURONIDATION,7,Down,0.625762463422894,0.946452158035139
538,WP_TRANSLATION_FACTORS,49,Down,0.626204881644266,0.946452158035139
539,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.626935098660771,0.946452158035139
540,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.631029992242356,0.946452158035139
541,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Up,0.63201425207524,0.946452158035139
542,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.633046375704204,0.946452158035139
543,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.63408383270761,0.946452158035139
544,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.634377319002092,0.946452158035139
545,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,85,Down,0.6348833879329,0.946452158035139
546,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.635028474035501,0.946452158035139
547,WP_TRANSSULFURATION_PATHWAY,8,Down,0.635328290221742,0.946452158035139
548,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.635616327587045,0.946452158035139
549,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.638165979238192,0.946452158035139
550,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.639120985085325,0.946452158035139
551,WP_SLEEP_REGULATION,10,Down,0.64013195239501,0.946452158035139
552,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.641220918263888,0.946452158035139
553,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.641798474100341,0.946452158035139
554,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.645989713703002,0.946452158035139
555,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.64665828777528,0.946452158035139
556,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.64822747309735,0.946452158035139
557,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.649656803261988,0.946452158035139
558,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,30,Down,0.649657065895102,0.946452158035139
559,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,119,Down,0.650601786915658,0.946452158035139
560,WP_ANGIOGENESIS,13,Down,0.651094224291533,0.946452158035139
561,WP_EICOSANOID_SYNTHESIS,14,Down,0.653119348203404,0.946452158035139
562,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.655718594888874,0.946452158035139
563,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,21,Up,0.656746314876877,0.946452158035139
564,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,20,Up,0.657685970027291,0.946452158035139
565,WP_CREATINE_PATHWAY,2,Down,0.661350124284674,0.946452158035139
566,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.663401780912621,0.946452158035139
567,WP_LUNG_FIBROSIS,30,Down,0.663412883325429,0.946452158035139
568,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.664575300041546,0.946452158035139
569,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,52,Down,0.666471098139881,0.946452158035139
570,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,14,Up,0.667737933922639,0.946452158035139
571,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,13,Up,0.667974896330455,0.946452158035139
572,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Down,0.66814957284996,0.946452158035139
573,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,40,Up,0.669345088814595,0.946452158035139
574,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.67155008339267,0.946452158035139
575,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.671761797776803,0.946452158035139
576,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Down,0.674079646217075,0.946452158035139
577,WP_FRAGILE_X_SYNDROME,83,Down,0.674591712720156,0.946452158035139
578,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.6756971841197,0.946452158035139
579,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,63,Up,0.676645164166065,0.946452158035139
580,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.678355865547682,0.946452158035139
581,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,31,Down,0.678718333318876,0.946452158035139
582,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.678868359674379,0.946452158035139
583,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,11,Down,0.680353290723754,0.946452158035139
584,WP_P38_MAPK_SIGNALING,31,Down,0.680728588532197,0.946452158035139
585,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.681614347954606,0.946452158035139
586,WP_NRXN1_DELETION_SYNDROME,2,Down,0.682784612762403,0.946452158035139
587,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.68363096800173,0.946452158035139
588,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,56,Down,0.683691776713669,0.946452158035139
589,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.685432755760732,0.946452158035139
590,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.685966885474519,0.946452158035139
591,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.686420016141384,0.946452158035139
592,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.689944677825813,0.946452158035139
593,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.690168807180185,0.946452158035139
594,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,64,Up,0.690448733372511,0.946452158035139
595,WP_PURINERGIC_SIGNALING,14,Up,0.690779051579162,0.946452158035139
596,WP_CELLULAR_PROTEOSTASIS,6,Down,0.692355520756738,0.946452158035139
597,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.694642103902486,0.946452158035139
598,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,16,Down,0.697801212573299,0.946452158035139
599,WP_WNT_SIGNALING_AND_PLURIPOTENCY,58,Up,0.698099207064283,0.946452158035139
600,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.698695614424766,0.946452158035139
601,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.698785640060831,0.946452158035139
602,WP_IL19_SIGNALING,20,Up,0.699246132522511,0.946452158035139
603,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.701606555797537,0.946452158035139
604,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.701737861270636,0.946452158035139
605,WP_KIT_RECEPTOR_SIGNALING,52,Down,0.70205455267936,0.946452158035139
606,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.702168239323804,0.946452158035139
607,WP_PDGFRBETA_PATHWAY,28,Up,0.703055576130045,0.946452158035139
608,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.703110064260267,0.946452158035139
609,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Down,0.704326576430678,0.946452158035139
610,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Down,0.704558133034963,0.946452158035139
611,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Down,0.705022491305442,0.946452158035139
612,WP_NRF2ARE_REGULATION,20,Up,0.705088101648473,0.946452158035139
613,WP_TRYPTOPHAN_METABOLISM,17,Down,0.70656221038259,0.946452158035139
614,WP_STEROID_BIOSYNTHESIS,2,Down,0.706960614396077,0.946452158035139
615,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.710044136535349,0.947548540688344
616,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.710330008649341,0.947548540688344
617,WP_IL6_SIGNALING,39,Up,0.711237773241737,0.947548540688344
618,WP_5Q35_COPY_NUMBER_VARIATION,76,Up,0.713865333434038,0.947695347017324
619,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,29,Down,0.714093883418847,0.947695347017324
620,WP_MALE_INFERTILITY,70,Up,0.715744456723356,0.947695347017324
621,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.715959623476592,0.947695347017324
622,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.717347795243838,0.948006250306165
623,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Up,0.7195987044302,0.948842146783565
624,WP_DNA_DAMAGE_RESPONSE,63,Up,0.720914138433167,0.948842146783565
625,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,15,Up,0.72144323812619,0.948842146783565
626,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,38,Down,0.723810560662073,0.949541409790298
627,WP_VITAMIN_B12_DISORDERS,9,Down,0.724285235934935,0.949541409790298
628,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,53,Up,0.726131921464826,0.950243693203927
629,WP_TCA_CYCLE_IN_SENESCENCE,9,Up,0.727132947719307,0.950243693203927
630,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.729845692936254,0.951231975081175
631,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,45,Up,0.731783904841311,0.951231975081175
632,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.732089195937184,0.951231975081175
633,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,19,Up,0.732518053803387,0.951231975081175
634,WP_ENDOCHONDRAL_OSSIFICATION,27,Up,0.736581459504493,0.951390160638384
635,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,27,Up,0.736581459504493,0.951390160638384
636,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Down,0.737124936004383,0.951390160638384
637,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.739406137545052,0.951390160638384
638,WP_CHOLESTEROL_METABOLISM,50,Down,0.739903754155657,0.951390160638384
639,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.739986639011089,0.951390160638384
640,WP_TCELL_ACTIVATION_SARSCOV2,62,Up,0.740741730910664,0.951390160638384
641,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,60,Up,0.744616764712133,0.954875164732252
642,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.746327159176009,0.95557776455246
643,WP_GLIOBLASTOMA_SIGNALING,68,Down,0.749008690667789,0.956564213160573
644,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.751814491124268,0.956564213160573
645,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Down,0.752308509763189,0.956564213160573
646,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.752613745244793,0.956564213160573
647,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,52,Down,0.754313922996597,0.956564213160573
648,WP_NEUROINFLAMMATION,10,Down,0.755266209998218,0.956564213160573
649,WP_NONSMALL_CELL_LUNG_CANCER,60,Down,0.755694805937685,0.956564213160573
650,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.757562450077409,0.956564213160573
651,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,34,Up,0.759643597592635,0.956564213160573
652,WP_RAS_SIGNALING,115,Down,0.759805413198083,0.956564213160573
653,WP_IL3_SIGNALING,46,Up,0.75989833478571,0.956564213160573
654,WP_GPR40_PATHWAY,10,Up,0.769641050243428,0.963468043311467
655,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Up,0.770663417563128,0.963468043311467
656,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.770675682490495,0.963468043311467
657,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Down,0.770725171841158,0.963468043311467
658,WP_15Q25_COPY_NUMBER_VARIATION,27,Up,0.77264066547693,0.963468043311467
659,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,69,Down,0.773626906410746,0.963468043311467
660,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,10,Up,0.773748413447673,0.963468043311467
661,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.774759582273576,0.963468043311467
662,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.776051207903454,0.963616454526646
663,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,65,Down,0.778836577931202,0.965616390738232
664,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Down,0.780231851161403,0.965889430202822
665,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,10,Down,0.783338793185012,0.967330905435581
666,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.785609960079046,0.967330905435581
667,WP_COPPER_HOMEOSTASIS,40,Down,0.785652532181155,0.967330905435581
668,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Up,0.788677877639985,0.967330905435581
669,WP_BLADDER_CANCER,29,Down,0.789513011121982,0.967330905435581
670,WP_METABOLIC_EPILEPTIC_DISORDERS,58,Up,0.791072625949243,0.967330905435581
671,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.791913684203335,0.967330905435581
672,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.79227052571004,0.967330905435581
673,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.792727689150536,0.967330905435581
674,WP_ZINC_HOMEOSTASIS,23,Up,0.793164270393651,0.967330905435581
675,WP_WNT_SIGNALING_WP428,56,Down,0.795836684314706,0.967896892897186
676,WP_CANCER_PATHWAYS,300,Down,0.796606692679894,0.967896892897186
677,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Up,0.797431421071092,0.967896892897186
678,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.79918074049041,0.967896892897186
679,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,12,Up,0.799515803256921,0.967896892897186
680,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.80155992059574,0.968187991351899
681,WP_VITAMIN_D_METABOLISM,6,Up,0.806004948136411,0.968187991351899
682,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.806249237791278,0.968187991351899
683,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.806264512721547,0.968187991351899
684,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.809730959979295,0.968187991351899
685,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Up,0.812016026165084,0.968187991351899
686,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.813927271249836,0.968187991351899
687,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.814465917708016,0.968187991351899
688,WP_MITOCHONDRIAL_GENE_EXPRESSION,17,Up,0.814977932065844,0.968187991351899
689,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,48,Down,0.815894644096382,0.968187991351899
690,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.817165367071086,0.968187991351899
691,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.817850004228651,0.968187991351899
692,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,163,Up,0.818770015768284,0.968187991351899
693,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.81895851665697,0.968187991351899
694,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.819419595088153,0.968187991351899
695,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,11,Down,0.820562346902537,0.968187991351899
696,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Up,0.822511822877088,0.968187991351899
697,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.822926912614671,0.968187991351899
698,WP_COMPLEMENT_ACTIVATION,12,Down,0.823432679355621,0.968187991351899
699,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Up,0.827120325178702,0.968187991351899
700,WP_RAC1PAK1P38MMP2_PATHWAY,52,Down,0.828933060946524,0.968187991351899
701,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.828982397571722,0.968187991351899
702,WP_NGLYCAN_BIOSYNTHESIS,52,Up,0.830653122757717,0.968187991351899
703,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,19,Up,0.831858284928421,0.968187991351899
704,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.832341065086639,0.968187991351899
705,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.834508337470534,0.968187991351899
706,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.836219632211816,0.968187991351899
707,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.836930859502626,0.968187991351899
708,WP_NPHP1_DELETION_SYNDROME,10,Up,0.836935476255379,0.968187991351899
709,WP_CCL18_SIGNALING,20,Up,0.837291036511957,0.968187991351899
710,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,4,Up,0.841508672818814,0.968187991351899
711,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,124,Up,0.842543259196046,0.968187991351899
712,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Up,0.842827338516928,0.968187991351899
713,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.843885095324019,0.968187991351899
714,WP_ALZHEIMERS_DISEASE,184,Down,0.843938178231059,0.968187991351899
715,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Down,0.843938178231059,0.968187991351899
716,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.844505595283164,0.968187991351899
717,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.844659013367989,0.968187991351899
718,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Up,0.845692187093265,0.968187991351899
719,WP_NEPHROTIC_SYNDROME,29,Up,0.849474665414987,0.970022555675506
720,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Down,0.849654793292414,0.970022555675506
721,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,11,Up,0.85196418317581,0.970025172753342
722,WP_HEPATITIS_B_INFECTION,116,Down,0.854031096430311,0.970025172753342
723,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Up,0.854037695483634,0.970025172753342
724,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Down,0.854377402765717,0.970025172753342
725,WP_ENDOMETRIAL_CANCER,49,Up,0.857200844802281,0.970779939300095
726,WP_PPARALPHA_PATHWAY,15,Up,0.857689962689636,0.970779939300095
727,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,2,Up,0.858585177458843,0.970779939300095
728,WP_IL5_SIGNALING,37,Up,0.862589305425902,0.972445596342396
729,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,12,Up,0.86268764069925,0.972445596342396
730,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,60,Down,0.865887448563037,0.972445596342396
731,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.867680432046933,0.972445596342396
732,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.86845110470938,0.972445596342396
733,WP_THERMOGENESIS,73,Down,0.869693751456346,0.972445596342396
734,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Up,0.871476027481761,0.972445596342396
735,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,23,Up,0.871487897459911,0.972445596342396
736,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,267,Down,0.87164284601865,0.972445596342396
737,WP_ATM_SIGNALING,37,Down,0.873023485133086,0.972445596342396
738,WP_OVARIAN_INFERTILITY,23,Down,0.873071593796457,0.972445596342396
739,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,45,Down,0.877154082684121,0.975342735428933
740,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,42,Up,0.878045771554028,0.975342735428933
741,WP_SPHINGOLIPID_PATHWAY,20,Down,0.880780927547273,0.976613071334041
742,WP_GASTRIC_CANCER_NETWORK_1,21,Up,0.883021455467403,0.976613071334041
743,WP_HUNGER_AND_SATIETY,2,Down,0.883966141759828,0.976613071334041
744,WP_COMPLEMENT_SYSTEM,51,Down,0.88446764890136,0.976613071334041
745,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Down,0.88682312553552,0.976613071334041
746,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Down,0.887254932128556,0.976613071334041
747,WP_FLUOROPYRIMIDINE_ACTIVITY,27,Down,0.887506039278015,0.976613071334041
748,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.889078354872919,0.97699584360139
749,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.890879155146464,0.97699584360139
750,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.891419565329736,0.97699584360139
751,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.892761659864574,0.977163894019547
752,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.896115932629989,0.977468237522723
753,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,51,Down,0.897134229712558,0.977468237522723
754,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.898537498840944,0.977468237522723
755,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.899845620107434,0.977468237522723
756,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.899876175652206,0.977468237522723
757,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Down,0.900174520443675,0.977468237522723
758,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Up,0.90458476323675,0.979917360758344
759,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,7,Up,0.905757983635112,0.979917360758344
760,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.906373628347445,0.979917360758344
761,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,44,Down,0.90930550342279,0.979917360758344
762,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Up,0.91144700547924,0.979917360758344
763,WP_DISORDERS_IN_KETOLYSIS,5,Up,0.911481875391455,0.979917360758344
764,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Down,0.912273139258672,0.979917360758344
765,WP_RETINOL_METABOLISM,6,Up,0.912403115746405,0.979917360758344
766,WP_APOPTOSIS_MODULATION_AND_SIGNALING,76,Down,0.91315900041471,0.979917360758344
767,WP_HISTONE_MODIFICATIONS,37,Up,0.916109590227537,0.981090636778297
768,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,18,Up,0.917726564131722,0.981090636778297
769,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Up,0.917832967983589,0.981090636778297
770,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Up,0.919633735179475,0.981738870542245
771,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.92199896137767,0.982987219523275
772,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.925160946379403,0.9830702956134
773,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.925328419424561,0.9830702956134
774,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Up,0.925963692186591,0.9830702956134
775,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.926860680170785,0.9830702956134
776,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Up,0.928122608463428,0.98314018576925
777,WP_GPCRS_CLASS_A_RHODOPSINLIKE,40,Up,0.930046348546293,0.983214537537554
778,WP_IL17_SIGNALING,25,Up,0.930585048910239,0.983214537537554
779,WP_CELL_CYCLE,107,Down,0.934062747840714,0.983350148559514
780,WP_NRF2_PATHWAY,66,Up,0.934101043681202,0.983350148559514
781,WP_APOPTOSIS,71,Up,0.934302270103382,0.983350148559514
782,WP_AUTOPHAGY,27,Down,0.936207265019099,0.984095104662019
783,WP_MIRNA_BIOGENESIS,6,Up,0.940824860514272,0.985429924329727
784,WP_IL4_SIGNALING,50,Down,0.941674689511242,0.985429924329727
785,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,27,Up,0.941691794660208,0.985429924329727
786,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Down,0.943667410629775,0.985429924329727
787,WP_HEDGEHOG_SIGNALING_WP4249,25,Up,0.946033497004082,0.985429924329727
788,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.946082864134866,0.985429924329727
789,WP_VALPROIC_ACID_PATHWAY,8,Up,0.946887789528182,0.985429924329727
790,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,53,Down,0.947934522006725,0.985429924329727
791,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.948266508691987,0.985429924329727
792,WP_G13_SIGNALING,30,Up,0.949678182147233,0.985650840561901
793,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,90,Up,0.950898508368378,0.985672854828256
794,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,74,Up,0.952864516495752,0.98646679163666
795,WP_BREAST_CANCER_PATHWAY,88,Down,0.955207419488984,0.98764842618861
796,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,75,Up,0.959426311211681,0.990764356552766
797,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Up,0.961663057347464,0.991828146975678
798,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.964626450339903,0.993637772154637
799,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.966553656843178,0.994376853473207
800,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Up,0.970257324057039,0.996939400468608
801,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.974792444991054,0.998059641819047
802,WP_PROTEASOME_DEGRADATION,57,Down,0.977609979735525,0.998059641819047
803,WP_G_PROTEIN_SIGNALING,61,Up,0.978110403558728,0.998059641819047
804,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,42,Up,0.981257711206074,0.998059641819047
805,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Up,0.981425496099874,0.998059641819047
806,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.981883139179716,0.998059641819047
807,WP_PHOSPHOINOSITIDES_METABOLISM,39,Up,0.983687056100276,0.998059641819047
808,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,40,Down,0.984002504928852,0.998059641819047
809,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Down,0.984021559150895,0.998059641819047
810,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.985394861785911,0.998059641819047
811,WP_AEROBIC_GLYCOLYSIS,10,Up,0.985917797028061,0.998059641819047
812,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.985917797028061,0.998059641819047
813,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.987359856883726,0.998239380492848
814,WP_CYTOSINE_METHYLATION,7,Up,0.988524155378562,0.998239380492848
815,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.990476777629913,0.998582147901612
816,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.99220135159924,0.998582147901612
817,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,17,Down,0.992822805750775,0.998582147901612
818,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,28,Down,0.995875715424887,0.998582147901612
819,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.99598781356692,0.998582147901612
820,WP_BDNFTRKB_SIGNALING,27,Up,0.997174162952791,0.998582147901612
821,WP_NOTCH_SIGNALING_WP61,49,Up,0.997584044342696,0.998582147901612
822,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Down,0.998582147901612,0.998582147901612
